• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZOLL CIRCULATION, INC AUTOPULSE LI-ION BATTERY¿; SECONDARY BATTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZOLL CIRCULATION, INC AUTOPULSE LI-ION BATTERY¿; SECONDARY BATTERY Back to Search Results
Model Number 100
Medical Device Problem Code Battery Problem (2885)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/20/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The autopulse li-ion battery (sn (b)(6) will not be returned to zoll for investigation.The customer acknowledged they had received the zoll recall notification letter on sept 1, 2022.The death was not related to the autopulse device.The autopulse is used as an adjunct to manual cpr, adjunctive use only indication is prominently displayed on device labels and in the device manual.The benefit of using the autopulse is that it in part substitutes mechanical compressions for the physical labor of manual chest compressions when effective manual cpr is not possible.If the autopulse did not start or unexpectedly stops compressions, rescuer should revert to manual cpr, which is the standard of care.The autopulse is intended to be used as an adjunct to manual cpr on adult patients.In case of stoppage of autopulse the trained user reverts to manual cpr.The transition from autopulse to manual cpr by trained users is similar to the time necessary for rescuer rotation and presents the same workflow as manual cpr.Hence, based on available information, the patients' outcome was not negatively impacted by the interruptions when compared to standard of care manual cpr.Out-of-hospital cardiac arrest (ohca) is one of the main causes of death in industrial nations.About 25% of patients survive this event and make it to the hospital, and even fewer patients survive after 24 hours (nichol, nejm, 2015).Survival to hospital discharge after non-traumatic emergency medical services-treated cardiac arrest with any first recorded rhythm was around 10% for patients of any age (mozaffarian, circulation, 2016; ebiomedicine 2023).Death is an expected outcome for ohca.
 
Event or Problem Description
During a cpr call, the fully charged autopulse li-ion batteries (sn (b)(6)) would not power on the autopulse platform.The batteries showed as fully charged on the multi-chemistry battery charger before use in the platform.Manual cpr was performed.The patient did not survive.Per the customer, the use of autopulse platform wouldn't have changed the patient's outcome.The platform is performing as intended using known good batteries and the battery issue was replicated in the station after the call.
 
Additional Manufacturer Narrative
The reported complaint that the fully charged autopulse li-ion battery (sn 12256) would not power on the autopulse platform was not confirmed during functional testing and archive data review.No device malfunction was observed during testing, and the battery functioned as intended.The battery archive was downloaded and reviewed.No errors or anomalies were found in archive.The battery passed charging in a known good autopulse multi-chemistry battery charger (mcc), and the status leds on the battery showed four solid green lights after the successful charging attempt.The battery was able to power the autopulse platform for 30 minutes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AUTOPULSE LI-ION BATTERY¿
Common Device Name
SECONDARY BATTERY
Manufacturer (Section D)
ZOLL CIRCULATION, INC
2000 ringwood ave
san jose CA 95131
Manufacturer (Section G)
ZOLL CIRCULATION INC
2000 ringwood ave
san jose CA 95131
Manufacturer Contact
kimthoa sackrison
2000 ringwood ave
san jose, CA 95131
4084192922
MDR Report Key19727454
Report Number3010617000-2024-00548
Device Sequence Number20869924
Product Code DRM
UDI-Device Identifier00849111001823
UDI-Public00849111001823
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
PMA/510(K) Number
K112998
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,User Facility,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 10/31/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number100
Device Catalogue Number8700-0752-01
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/20/2024
Supplement Date Received by Manufacturer10/18/2024
Initial Report FDA Received Date07/12/2024
Supplement Report FDA Received Date10/31/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/25/2022
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Reuse
Patient Sequence Number1
Patient Age50 YR
Patient SexMale
-
-